Delivery Order SPE2DB20D1109-SPE2DB25FP48S
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 75mg Nucynta tablets, valued at approximately $8.0K. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 8, 2025, with performance occurring at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement executed through the company's existing contract vehicle with DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta 50 mg tablets in quantities of 100 units, valued at $1,747.02. This competitively awarded, firm fixed-price contract was established on August 1, 2025, with an ultimate completion date of August 4, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under a larger contract vehicle....
- The Defense Logistics Agency awarded a delivery order valued at $2,849.76 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Nucynta 100 mg tablets (100-count). The contract reflects a firm fixed-price arrangement with an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside delivery order was competitively awarded and represents a routine pharmaceutical procurement within...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units) valued at $4,050.39. This firm fixed-price contract, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) with a completion date of August 11, 2025. This competitively awarded, non-set-aside contract operates under a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Nucynta 50 mg tablets (100 count) with a ceiling value of $1,225.04. This firm fixed-price delivery order, with an ultimate completion date of July 23, 2025, represents a direct fulfillment of pharmaceutical needs through the federal medical supply chain. The contract is not set-aside and was competitively awarded, reflecting AmerisourceBergen's established capability as a...
- The Defense Logistics Agency Troop Support Medical awarded a $578 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 tablets of 75mg Nucynta. As the prime contractor, Amerisourcebergen Drug will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by September 11, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award provided. The delivery order was issued against...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,240.67 to AmerisourceBergen Drug Corp for the supply of Nucynta Tabs 100mg, a pain management pharmaceutical product. The contract is firm fixed price with no set-aside designation, indicating it was competitively awarded. The delivery order is scheduled for completion by July 31, 2025, and performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.15 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count) on August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a controlled-release pain management pharmaceutical, valued at $1,205.75. The contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive award procedures. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP48SDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of Nucynta 75 mg tablets (100 count) valued at $1,432.38 under a firm fixed price contract. The award, issued on July 30, 2025, with a completion date of July 31, 2025, represents a small-value pharmaceutical procurement with no set-aside designation. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a diverse range of medications and medical commodities to support military healthcare systems worldwide. The delivery order for this pain management pharmaceutical demonstrates the company's ongoing role as a critical vendor within the DLA's pharmaceutical supply chain supporting defense health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/30/25 |